Core Laboratories

18.56
+0.42
+2.32%
CLB
 18.76 18.29 36.39万股总市值 8.64亿
 18.10 0.78% 674.16万市盈TTM 27.17
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
Core Laboratories(CLB)
02-13 05:25  
$Core Laboratories(CLB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001102578-26-000011  Act: 34  Size: 6 KB 网页链接
用户头像
Core Laboratories(CLB)
02-05 06:05  
$Core Laboratories(CLB)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-26-037789  Act: 34  Size: 1 MB 网页链接
用户头像
Core Laboratories(CLB)
01-06 04:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-002248  Size: 8 KB 网页链接
用户头像
Core Laboratories(CLB)
01-06 04:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-002252  Size: 8 KB 网页链接
用户头像
Core Laboratories(CLB)
01-06 04:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-002257  Size: 9 KB 网页链接
用户头像
Core Laboratories(CLB)
01-06 04:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-002254  Size: 8 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-12-03 08:45  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-305634  Size: 8 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-11-15 04:45  
$Core Laboratories(CLB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001050442-25-000038  Act: 34  Size: 6 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-11-15 00:25  
$Core Laboratories(CLB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000936753-25-000081  Act: 34  Size: 7 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-10-31 03:25  
$Core Laboratories(CLB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-25-000111  Act: 34  Size: 6 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-10-24 04:15  
$Core Laboratories(CLB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-248736  Act: 34  Size: 11 MB 网页链接
用户头像
Core Laboratories(CLB)
2025-10-23 04:25  
$Core Laboratories(CLB)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-25-246793  Act: 34  Size: 2 MB 网页链接
用户头像
Core Laboratories(CLB)
2025-10-03 05:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-228644  Size: 8 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-10-03 05:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-228649  Size: 9 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-08-15 05:35  
$Core Laboratories(CLB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001050442-25-000025  Act: 34  Size: 6 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-08-05 21:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-102459  Size: 13 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-08-05 21:25  
$Core Laboratories(CLB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-102465  Size: 9 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-07-29 23:25  
$Core Laboratories(CLB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000932471-25-000782  Act: 34  Size: 6 KB 网页链接
用户头像
Core Laboratories(CLB)
2025-07-25 18:05  
$Core Laboratories(CLB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-098473  Act: 34  Size: 11 MB 网页链接
用户头像
Core Laboratories(CLB)
2025-07-24 04:25  
$Core Laboratories(CLB)$ 8-K Current report, items 1.01, 2.02, 2.03, 7.01, and 9.01 Accession Number: 0000950170-25-097897  Act: 34  Size: 4 MB 网页链接